New Zealand markets closed

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
164.66+0.41 (+0.25%)
At close: 04:00PM EDT
164.99 +0.33 (+0.20%)
After hours: 07:55PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
4,863,000
4,863,000
11,836,000
11,542,000
4,616,000
Depreciation & amortisation
8,698,000
8,698,000
8,467,000
8,521,000
6,471,000
Deferred income taxes
-2,889,000
-2,889,000
-1,931,000
-898,000
-2,325,000
Stock-based compensation
747,000
747,000
671,000
692,000
753,000
Change in working capital
2,813,000
2,813,000
-94,000
-1,231,000
106,000
Accounts receivable
66,000
66,000
-1,455,000
-1,321,000
-929,000
Inventory
-417,000
-417,000
-686,000
-142,000
-40,000
Accounts payable
3,840,000
3,840,000
1,769,000
1,719,000
1,514,000
Other working capital
22,062,000
22,062,000
24,248,000
21,990,000
16,790,000
Other non-cash items
4,811,000
4,811,000
3,144,000
3,999,000
7,992,000
Net cash provided by operating activities
22,839,000
22,839,000
24,943,000
22,777,000
17,588,000
Cash flows from investing activities
Investments in property, plant and equipment
-777,000
-777,000
-695,000
-787,000
-798,000
Acquisitions, net
-1,223,000
-1,223,000
-794,000
-1,902,000
-39,610,000
Purchases of investments
-77,000
-77,000
-1,438,000
-119,000
-61,000
Sales/maturities of investments
55,000
55,000
1,530,000
98,000
1,525,000
Other investing activities
13,000
13,000
774,000
366,000
1,387,000
Net cash used for investing activities
-2,009,000
-2,009,000
-623,000
-2,344,000
-37,557,000
Cash flows from financing activities
Debt repayment
-4,149,000
-4,149,000
-14,433,000
-9,414,000
-5,683,000
Common stock repurchased
-1,972,000
-1,972,000
-1,487,000
-934,000
-978,000
Dividends paid
-10,539,000
-10,539,000
-10,043,000
-9,261,000
-7,716,000
Other financing activities
-742,000
-742,000
-1,102,000
-674,000
-333,000
Net cash used provided by (used for) financing activities
-17,222,000
-17,222,000
-24,803,000
-19,039,000
-11,501,000
Net change in cash
3,613,000
3,613,000
-545,000
1,297,000
-31,475,000
Cash at beginning of period
9,201,000
9,201,000
9,746,000
8,449,000
39,924,000
Cash at end of period
12,814,000
12,814,000
9,201,000
9,746,000
8,449,000
Free cash flow
Operating cash flow
22,839,000
22,839,000
24,943,000
22,777,000
17,588,000
Capital expenditure
-777,000
-777,000
-695,000
-787,000
-798,000
Free cash flow
22,062,000
22,062,000
24,248,000
21,990,000
16,790,000